[瘤免疫疗法 - 机制和副作用]
Christian Diehl1, Sacha Rothschild1
1Kantonsspital Baden, Zentrum für Onkologie Hämatologie, Baden.
Therapeutische Umschau. Revue therapeutique
|November 16, 2023
概括
免疫检查点抑制剂已经推进了癌症免疫疗法,但耐药性和与免疫相关的不良事件 (irAEs) 仍然是挑战. 本综述探讨了irAE机制,预防和治疗策略,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了癌症治疗,改善了各种瘤的反应和生存率.
- 然而,耐药性机制限制了持久反应,免疫相关不良事件 (irAEs) 带来了重大的临床挑战.
- 导致IRAE的确切机制尚未完全阐明.
研究的目的:
- 审查免疫检查点抑制剂的作用机制.
- 总结各种形式的irAEs及其潜在的发展途径.
- 概述目前和潜在的预防和治疗irAEs的战略.
主要方法:
- 关于免疫检查点抑制机制的综合文献综述.
- 分析报告的与免疫相关的不良事件及其建议的病因.
- 综合有关irAE预防和管理策略的证据.
主要成果:
- ICI通过释放免疫系统的车来准癌细胞来起作用.
- IRAE以各种形式表现,由于免疫活动的广泛性,影响多个器官系统.
- 了解ICI机制和irAE开发对于优化治疗策略至关重要.
结论:
- 虽然ICI提供了显著的治疗益处,但解决耐药性和irAEs对于改善患者结果至关重要.
- 需要对irAE病原体进行进一步的研究,以开发更有效的预防和治疗方案.
- 结合机理学理解与临床策略的多方面的方法对于最大限度地发挥癌症免疫疗法的潜力至关重要.
更多相关视频
相关概念视频
Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cytotoxic T Cells-mediated Immune Response
924
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
924
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


